Pentosidine (1 mg vial)
Product overview
- Catalog Number
- PPH08-0921
- Sequence
- (S)-2-Amino-6-(2-(((S)-4-Amino-4-Carboxybutyl)Amino)-4H-Imidazo[4,5-b]Pyridin-4-yl)Hexanoic Acid
- Target
- Advanced Glycation End Product (AGE) / Biomarker for Glycation-Oxidative Stress (e.g. in Diabetes)
- Description
- Pentosidine is a biomarker for advanced glycation endproducts, or AGEs. It is a well characterized and easily detected member of this large class of compounds. Advanced glycation end products (AGEs) are compounds formed by non-enzymatic chemical reactions following the bonding of sugars to proteins or lipids during diabetes, uremia, aging, rheumatic arthritis, and other conditions. A receptor for the AGEs (RAGE) binds certain members of this class to initiate cell signaling. Pentosidine is a well-characterized natural AGE that is often used as a biomarker for the production of all AGEs. While pentosidine can be measured in urine, the majority of this AGE is catabolized before excretion. AYEKKSTZQYEZPU-UHFFFAOYSA-N. 124505-87-9. C17H26N6O4. MW 378.4.
Category
Product Properties
| Quantity | 1mg |
|---|---|
| Storage | Shipped at 4°C. Store at -20°C for one year. |
| Purity | > 95% |
| Source | Synthetic |
| Forma appearance | Lyophilized powder |
| Price | €80,00 |
- For research use only
- Not for use in diagnostic procedures
€80,00 Tax excluded
Contact us to request price here
Register to buy peptides
Contact us